Trial intelligence / Profile preview

Inhalation Ethanol Therapy in COVID-19

IRCT20210725051981N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ethanol in coronavirus disease 2019 (COVID-19), sponsored by Isfahan University of Medical Sciences. Started Oct 2021; status: completed.

02

Drugs

ethanol
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on IRCT20210725051981N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210725051981N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call